Cochrane · systematic review · CD011804

Antipsychotics for fibromyalgia in adults

Walitt, B, Klose, P, Üçeyler, N, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
1
Included studies
NR
No studies 1 · 14.3%Ungraded 0 · 0%Very low 6 · 85.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: adults with fibromyalgia
7 questions
OutcomeEffectEvidenceStatus / GRADE
At least 50 % pain relief
no estimate extracted2 studies · 155 participantsVery low
Downgraded: risk of bias
Patient Global Impression of Change much or very much improved
no estimate extractedNRNo studies
Sleep problems (Scale 0 to 21; higher scores indicate more sleep problems)
no estimate extracted2 studies · 87 participantsVery low
Downgraded: risk of bias
Depression (Scale 0 to 50)
no estimate extracted3 studies · 207 participantsVery low
Downgraded: risk of bias
Withdrawals due to adverse events
no estimate extracted2 studies · 155 participantsVery low
Downgraded: risk of bias
Serious adverse events
no estimate extracted3 studies · 206 participantsVery low
Downgraded: risk of bias
Substantial weight gain
no estimate extracted2 studies · 155 participantsVery low
Downgraded: risk of bias